No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs546763582 |
chr2:133669628-133669629 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs577480915 |
chr2:133669645-133669646 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs561962153 |
chr2:133669707-133669708 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs146391757 |
chr2:133669732-133669733 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs16843371 |
chr2:133669749-133669750 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs561287472 |
chr2:133669780-133669781 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs375642659 |
chr2:133669785-133669786 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs72994809 |
chr2:133669795-133669796 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
9 |
rs138524132 |
chr2:133669798-133669799 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs532493370 |
chr2:133669809-133669810 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs188755702 |
chr2:133669833-133669834 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs547996716 |
chr2:133669848-133669849 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs566124897 |
chr2:133669860-133669861 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs141123595 |
chr2:133669864-133669865 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs150265819 |
chr2:133669871-133669872 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs569323724 |
chr2:133669956-133669957 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs536691988 |
chr2:133669962-133669963 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs138911199 |
chr2:133669985-133669986 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs116214477 |
chr2:133670003-133670004 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs181439136 |
chr2:133670014-133670015 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs60127947 |
chr2:133670052-133670053 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs376915216 |
chr2:133670059-133670060 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs149408843 |
chr2:133670063-133670064 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs535749464 |
chr2:133670123-133670124 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs560985749 |
chr2:133670130-133670131 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs575600103 |
chr2:133670163-133670164 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs543881801 |
chr2:133670184-133670185 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs144772967 |
chr2:133670186-133670187 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs577299377 |
chr2:133670282-133670283 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs541130028 |
chr2:133670340-133670341 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs530484888 |
chr2:133670347-133670348 |
Weak transcription Enhancers
|
CpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs552205254 |
chr2:133670348-133670349 |
Weak transcription Enhancers
|
CpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs530193251 |
chr2:133670366-133670367 |
Weak transcription Enhancers
|
CpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs112803306 |
chr2:133670380-133670381 |
Weak transcription Enhancers
|
CpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs189428839 |
chr2:133670408-133670409 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs563687363 |
chr2:133670455-133670456 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs531088439 |
chr2:133670470-133670471 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs79268550 |
chr2:133670477-133670478 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs146714430 |
chr2:133670478-133670479 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs552184618 |
chr2:133670489-133670490 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs74443432 |
chr2:133670515-133670516 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs138400955 |
chr2:133670540-133670541 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs567795522 |
chr2:133670590-133670591 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs546330098 |
chr2:133670593-133670594 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs182589324 |
chr2:133670602-133670603 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs535686531 |
chr2:133670609-133670610 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs143907772 |
chr2:133670654-133670655 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs185861907 |
chr2:133670659-133670660 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs370571206 |
chr2:133670680-133670681 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs539335902 |
chr2:133670692-133670693 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|